 |
|
"Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia"
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by World Journal of Neuroscience, Vol.5 No.3, 2015
has been cited by the following article(s)：
-
[1] Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and …
Clinical interventions in aging 2017[2] Benzofuran and indole: A promising scaffold for drug development in Alzheimer's disease
ChemMedChem 2018 - No relevant information.